Delivery Order SPE2DB24D2011-SPE2DB25FBQTC

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.46 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.10 firm fixed-price delivery order is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 7, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,948.00 firm fixed-price delivery order contract is for the provision of 90-count tablets of Januvia 100mg, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 4, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,881.32 delivery order contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order, with a performance period extending through April 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held...
This federal contract award, valued at $56,925.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUVIA 100 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of January 9, 2025 and a pricing type of Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,261.46 delivery order contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price, non-set-aside award with a performance period through May 9, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.37 firm fixed-price delivery order is for the supply of JANUVIA 100 MG Tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,344.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,162.08 firm fixed-price delivery order is for the supply of JANUVIA 50 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQTC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,266.66 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 9, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to competition. This award demonstrates AmerisourceBergen Drug Corp's role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/10/25, 1:18 AM